These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3288651)

  • 1. Absence of the dawn phenomenon in normal subjects.
    Simon C; Brandenberger G; Follenius M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):203-5. PubMed ID: 3288651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of dawn phenomenon in normal children and adolescents.
    Marin G; Rose SR; Kibarian M; Barnes K; Cassorla F
    Diabetes Care; 1988 May; 11(5):393-6. PubMed ID: 3292169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal decrease in glucose tolerance during constant glucose infusion.
    Van Cauter E; Désir D; Decoster C; Féry F; Balasse EO
    J Clin Endocrinol Metab; 1989 Sep; 69(3):604-11. PubMed ID: 2668321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition.
    Simon C; Brandenberger G; Follenius M
    J Clin Endocrinol Metab; 1987 Apr; 64(4):669-74. PubMed ID: 3102544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion.
    Mauras N; Rogol AD; Clarke WL
    J Clin Endocrinol Metab; 1986 May; 62(5):975-9. PubMed ID: 3514653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a dawn phenomenon in normal adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Horm Res; 1990; 34(1):27-32. PubMed ID: 1963621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variation of basal and postprandial insulin sensitivity in healthy individuals and patients with type-1 diabetes.
    Tatò F; Tatò S; Beyer J; Schrezenmeir J
    Diabetes Res; 1991 May; 17(1):13-24. PubMed ID: 1816976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon.
    Kruszynska YT; Home PD
    Diabete Metab; 1988; 14(4):437-42. PubMed ID: 3066651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial oscillations of plasma glucose, insulin and C-peptide in man.
    Simon C; Follenius M; Brandenberger G
    Diabetologia; 1987 Oct; 30(10):769-73. PubMed ID: 3322902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved circadian rhythm of serum insulin concentration at low plasma glucose during fasting in lean and overweight humans.
    Merl V; Peters A; Oltmanns KM; Kern W; Hubold C; Hallschmid M; Born J; Fehm HL; Schultes B
    Metabolism; 2004 Nov; 53(11):1449-53. PubMed ID: 15536600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
    Beaufrère B; Beylot M; Metz C; Ruitton A; François R; Riou JP; Mornex R
    Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour profile of plasma glucose and glucoregulatory hormones during normal living conditions in trained and untrained men.
    Dela F; Mikines KJ; von Linstow M; Galbo H
    J Clin Endocrinol Metab; 1991 Nov; 73(5):982-9. PubMed ID: 1939536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-insulin-dependent diabetic patients (NIDDMs) do not demonstrate the dawn phenomenon at presentation.
    Atiea JA; Vora JP; Owens DR; Luzio S; Read GF; Walker RF; Hayes TM
    Diabetes Res Clin Pract; 1988 May; 5(1):37-44. PubMed ID: 3042344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of the dawn glucose rise in nondiabetic men compared by age.
    Rosenthal MJ; Argoud GM
    J Gerontol; 1989 Mar; 44(2):M57-61. PubMed ID: 2646356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.